Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
Yoshihisa Shitara, Masaru Hirano, Hitoshi Sato and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics October 2004, 311 (1) 228-236; DOI: https://doi.org/10.1124/jpet.104.068536
Yoshihisa Shitara
Masaru Hirano
Hitoshi Sato
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 311, Issue 1
1 Oct 2004
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
Yoshihisa Shitara, Masaru Hirano, Hitoshi Sato and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics October 1, 2004, 311 (1) 228-236; DOI: https://doi.org/10.1124/jpet.104.068536
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
Yoshihisa Shitara, Masaru Hirano, Hitoshi Sato and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics October 1, 2004, 311 (1) 228-236; DOI: https://doi.org/10.1124/jpet.104.068536
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement